General Information of the Compound
| Compound ID |
CP0133264
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
A-56268
Show/Hide
|
||||||||||||||||||
| Synonyms |
(14R)-14-Hydroxyclarithromycin
6-O-Methylerythromycin
6-O-Methylerythromycin a
A-56268
ANX-015
Abbotic
Abbott-56268
Adel
Astromen
Biaxin
Biaxin (TN)
Biaxin HP
Biaxin XL
Biaxin filmtab
Biaxin xl filmtab
Bicrolid
CLM & IL-12
CRL-1605 & Clarithromycin
CTY
Clacee
Clacid
Clacid (TN)
Clacine
Clambiotic
Clarem
Claribid
Claricide
Claridar
Claridar (TN)
Claripen
Claripen (TN)
Clarith
Clarithromycin
Clarithromycin & Interleukin-12
Clarithromycin (JP15/USP/INN)
Clarithromycin [USAN:INN:BAN:JAN]
Clarithromycin extended release
Clarithromycin suspension or tablets
Clarithromycina
Clarithromycine
Clarithromycine [INN-French]
Clarithromycinum
Clarithromycinum [INN-Latin]
Claritromicina
Claritromicina [INN-Spanish]
Clathromycin
Crixan
Crixan (TN)
Cyllid
Cyllind
DRG-0099
Erythromycin, 6-O-methyl-
Fromilid
Fromilid (TN);Infex (TN)
Helas
Heliclar
Hydro-2H-pyran-2-yl]oxy}-7-methoxy-3,5,7,9,11,13-hexame
Klabax
Klabax (TN)
Klacid
Klaciped
Klaricid
Klaricid (TN)
Klaricid H.P
Klaricid H.PKlaricid Pediatric
Klaricid XL
Klarid
Klarin
Klax
Kofron
Lactoferrin B & Clarithromycin
Lactoferrin H & Clarithromycin
Mabicrol
Macladin
Maclar
Mavid
Naxy
Naxy;Veclam
O(6)-methylerythromycin
SDP-015
TE-031
TE031
Veclam
Vikrol (TN)
Zeclar
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C38H69NO13
|
||||||||||||||||||
| Molecular Weight |
747.964
|
||||||||||||||||||
| Canonical SMILES |
CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
AGOYDEPGAOXOCK-KCBOHYOISA-N
|
||||||||||||||||||
| CAS |
81103-11-9
116836-41-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01546, ATP-dependent translocase ABCB1
Cell-based Assay
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Protein ID: PT03566, Solute carrier organic anion transporter family member 1B1
Protein ID: PT03657, Solute carrier organic anion transporter family member 1B3
Clinical Information about the Compound
Drug 1 ( Clarithromycin )
| Drug Name | Clarithromycin | ||
|---|---|---|---|
| Company | Abbott Laboratories | ||
| Indication | |||